USANA Health Sciences, Inc.
Consumer DefensiveNYSE:USNA · New York Stock Exchange
+$0.04 today
Vol 0.08M · Avg 0.12M
Balance Sheet
Inspect the capital base behind the business
Review assets, liabilities, equity, cash, and debt to judge whether the company has the financial position to support future returns.
Balance Sheet
Assets, liabilities & equity
| Cash & Equivalents | $162.8M |
| Receivables | $9.7M |
| Inventory | $96.4M |
| Other Current | $25.5M |
| Total Current Assets | $294.2M |
| PP&E (Net) | $94.6M |
| Goodwill | $138.1M |
| Intangible Assets | $128.9M |
| Tax Assets | $25.2M |
| Other Non-current | $57.9M |
| Total Non-current Assets | $444.7M |
| Total Assets | $739.0M |
Analysis
Selected assets total $739.0M for Latest. The largest visible component is Cash & Equivalents at $162.8M, about 22.0% of the tab total. Use the mix to judge balance sheet concentration, liquidity, leverage, and how much of book value is supported by tangible operating assets.
Balance Sheet
Annual data · 5 periods
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $158.4M -12.9% | $181.8M -45.0% | $330.4M +14.6% | $288.4M +20.3% | $239.8M | $1.0B | $841.8M | $673.8M |
| Short-term Investments | $0 | $0 | $0 | $0 | $0 | -$1.6B | $445.6M | $378.4M |
| Net Receivables | $0 -100.0% | $8.2M +14.2% | $7.2M -0.2% | $7.2M +0.7% | $7.2M | $533.8M | $399.4M | -$1.7B |
| Inventory | $102.6M +47.1% | $69.7M +13.5% | $61.5M -8.4% | $67.1M -31.8% | $98.3M | $641.6M | $328.0M | $316.8M |
| Other Current Assets | $27.4M +380.8% | $5.7M -21.6% | $7.3M +2.2% | $7.1M +93.5% | $3.7M | $1.5B | $966.4M | $764.8M |
| Total Current Assets | $288.4M +3.3% | $279.2M -33.2% | $417.7M +9.6% | $381.2M +5.1% | $362.8M | $12.5B | $10.5B | $5.5B |
| Property, Plant & Equipment (Net) | $94.4M -0.2% | $94.6M -5.3% | $99.8M -15.2% | $117.8M -6.2% | $125.6M | $1.2B | $1.5B | $687.8M |
| Goodwill | $138.0M -4.3% | $144.2M +743.0% | $17.1M -1.5% | $17.4M -1.7% | $17.7M | $925.8M | $466.6M | $309.8M |
| Intangible Assets | $133.2M -12.3% | $151.8M +407.4% | $29.9M -7.7% | $32.4M +6.5% | $30.4M | $568.8M | $860.0M | $1.5B |
| Long-term Investments | $0 -100.0% | $2.7M -3.0% | $2.8M -2.6% | $2.9M -87.8% | $23.8M | $524.0M | -$1.5B | $860.0M |
| Tax Assets | $27.2M +38.5% | $19.6M +47.9% | $13.3M +35.6% | $9.8M +102.5% | $4.8M | $1.5B | $1.4B | $1.4B |
| Other Non-current Assets | $61.8M +10.2% | $56.1M +7.7% | $52.1M +48.5% | $35.1M +179.2% | $12.6M | $1.4B | $1.0B | $679.4M |
| Total Non-current Assets | $454.5M -3.1% | $469.0M +118.1% | $215.0M -0.1% | $215.3M +0.2% | $214.9M | -$15.3B | $14.8B | $11.3B |
| Total Assets | $742.9M -0.7% | $748.2M +18.2% | $632.8M +6.1% | $596.5M +3.3% | $577.7M | $13.3B | $11.9B | $10.6B |
| Account Payables | $17.3M +44.1% | $12.0M +19.0% | $10.1M -8.9% | $11.0M -18.2% | $13.5M | $1.3B | -$1.5B | $1.4B |
| Short-term Debt | $14.0M -39.1% | $23.0M +2826.2% | $786.0K -88.6% | $6.9M -2.7% | $7.1M | -$1.6B | -$1.6B | $326.6M |
| Tax Payables | $0 -100.0% | $11.8M -6.1% | $12.5M +151.9% | $5.0M -4.2% | $5.2M | $574.4M | -$1.5B | $1.4B |
| Deferred Revenue | $0 -100.0% | $12.1M -13.4% | $13.9M -33.4% | $20.9M +6.3% | $19.6M | -$1.6B | $374.2M | $542.2M |
| Other Current Liabilities | $97.3M +2149.3% | -$4.7M -106.4% | $73.8M -10.8% | $82.7M -0.4% | $83.0M | $1.1B | $1.5B | $493.2M |
| Total Current Liabilities | $128.6M -7.9% | $139.6M +17.5% | $118.8M -17.4% | $143.8M -10.5% | $160.8M | $6.0B | $10.1B | $14.3B |
| Long-term Debt | $0 | $0 | $0 | $0 | $0 | $1.3B | $438.6M | $1.3B |
| Deferred Tax Liabilities | $4.9M +20.1% | $4.1M -10.5% | $4.6M +11.8% | $4.1M -45.7% | $7.5M | $746.6M | $612.2M | $477.8M |
| Deferred Revenue (Non-current) | $0 | $0 | $0 | $0 | $0 | -$1.6B | $715.8M | $1.3B |
| Other Non-current Liabilities | $23.2M +190.8% | $8.0M +13.6% | $7.0M -3.6% | $7.3M +77.0% | $4.1M | $489.0M | $1.1B | -$1.5B |
| Total Non-current Liabilities | $28.1M +26.3% | $22.2M +33.1% | $16.7M -8.4% | $18.2M -16.4% | $21.8M | $3.9B | $7.5B | $14.1B |
| Total Liabilities | $156.6M -3.2% | $161.9M +19.4% | $135.6M -16.4% | $162.1M -11.2% | $182.6M | $14.7B | $3.7B | $9.6B |
| Common Stock | $18.0K -5.3% | $19.0K +0.0% | $19.0K +0.0% | $19.0K +0.0% | $19.0K | $651.4M | $517.0M | $382.6M |
| Retained Earnings | $465.7M -2.8% | $478.9M +7.6% | $445.2M +13.7% | $391.6M +13.6% | $344.6M | -$1.6B | $519.8M | $1.1B |
| Accumulated OCI | -$16.2M +28.6% | -$22.7M -65.5% | -$13.7M -7.1% | -$12.8M -2891.9% | $458.0K | $393.8M | $550.6M | $707.4M |
| Other Stockholders Equity | $0 | $0 | $0 | $0 | $0 | $351.8M | -$1.6B | $1.5B |
| Minority Interest | $53.2M -1.9% | $54.2M | $0 | $0 | $0 | $1.4B | $337.8M | $931.4M |
| Total Equity | $586.3M -0.0% | $586.3M +17.9% | $497.2M +14.4% | $434.5M +10.0% | $395.1M | $9.1B | $7.7B | $3.3B |
| Total Debt | $14.0M -64.3% | $39.2M +196.9% | $13.2M -4.2% | $13.8M -20.3% | $17.3M | $724.2M | $410.6M | $399.4M |
| Net Debt | -$144.4M -1.3% | -$142.6M +55.1% | -$317.2M -15.5% | -$274.6M -23.4% | -$222.5M | $389.6M | $501.6M | $311.2M |
Older periods hidden.
Sign in to unlockCompetitors
Peer companies in the same sector
Westrock Coffee Company, LLC
NASDAQ:WEST
$926.80M
Mama's Creations, Inc.
NASDAQ:MAMA
$606.94M
Dingdong (Cayman) Limited
NYSE:DDL
$521.92M
Calavo Growers, Inc.
CVGW
$466.33M
Vasta Platform Limited
VSTA
$394.00M
Lifeway Foods, Inc.
NASDAQ:LWAY
$383.12M
BrasilAgro - Companhia Brasileira de Propriedades Agrícolas
NYSE:LND
$372.56M
B&G Foods, Inc.
NYSE:BGS
$327.10M
QuantaSing Group Ltd
QSG
$274.08M
BRC Inc.
NYSE:BRCC
$159.13M
SEC Filings
Recent regulatory filings
No filings found.
How much cash does USNA have?
USANA Health Sciences, Inc. (USNA) reported $158.38M in cash and equivalents in fiscal 2025.
How much debt does USNA carry?
USANA Health Sciences, Inc. (USNA) reported $14.00M of total debt, with net debt of -$144,380,000.00.
Explore More
Continue the stock analysis
Jump to another research area for this company.